Risk Factors ID’d for Severe COVID-19 With Sickle Cell Disease
Hydroxyurea use does not impact development of serious COVID-19 or need for hospitalization in children or adults
Review Compiles Myocarditis Cases Associated With COVID-19
COVID-19-related myocarditis profiled from 42 cases reported in articles published from December 2019 through January 5, 2021
U.S. Drug Overdose Deaths Up ~30 Percent in 2020
Increases seen in overdose deaths from opioids, as well as cocaine and psychostimulants
Athletes Have Higher Risk for Developing Atrial Fibrillation
Risk greater in athletes younger than 55 years and among those participating in mixed sport versus endurance sport
Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
Perceived Financial Barriers Hinder Cervical Cancer Screening
72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening
Pfizer Presses U.S. Scientists, Officials on Third Booster Shot
U.S. officials say that more data are needed before regulators can determine whether booster shots are necessary
Questionnaire Responses About Dermatology History Inconsistent
History of psoriasis consistently reported, whereas history of atopic dermatitis is not
Nearly Four in 10 With Mild COVID-19 Report Symptoms Seven Months Later
Fatigue remains the most common symptom among otherwise healthy people
Guidance Updated for Managing C. difficile Infection in Adults
Fidaxomicin suggested instead of vancomycin for initial Clostridioides difficile infection episode, recurrent CDI episodes
